Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.9963
-0.0137 (-1.36%)
At close: Jun 12, 2026, 4:00 PM EDT
1.050
+0.054 (5.39%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $3.89 million as of June 12, 2026. Its market cap has increased by 170.01% in one year.
Market Cap
3.89M
Enterprise Value
-9.46M
1-Year Change
170.01%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.89M, a decrease of -95.70%. That is a compound annual growth rate of -43.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.89M | -17.82% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 4.43M |
| Bio Green Med Solution | 4.32M |
| Adial Pharmaceuticals | 4.26M |
| Galmed Pharmaceuticals | 4.03M |
| Virax Biolabs Group | 3.67M |
| 60 Degrees Pharmaceuticals | 3.62M |
| GeoVax Labs | 3.53M |
| Azitra | 3.43M |